Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.
Request Insights
IN THE NEWSApril 30, 2022: DNA Forensics Laboratory to provide 3-step DNA tests to avoid baby swaps in hospitals at the time of their birth.
September 28, 2021: European Fertility Society recently launched the “Fertility Care Award” to promote and celebrate the excellent performance of the professionals to facilitate people trying to conceive.
The global sperm density testing market is estimated to garner notable revenue by growing at a ~6% CAGR over the forecast period, i.e., 2022 – 2031. The growth of the market can be accounted to factors, such as, rising cases of infertility in males, convenient access to fertility care, and others. According to data released by World Health Organization (WHO) in 2021, it was stated that 186 million individuals of the global population have infertility, meanwhile, 48 million couples suffer from infertility. Furthermore, an average sperm count is estimated to be between about 15 to 200 million sperm per mL of semen, however, this density can be lowered due to many factors, such as, smoking, obesity, alcohol consumption, and others. Such habits are responsible to reduce testosterone levels required for monitoring the production of the sperms. A report published by Harvard University demonstrated the fact that obese men showed low sperm count, and 81% more likely to produce no sperm. Additionally, a higher prevalence of obesity is observed in the global population in recent decades. Such factors are estimated to boost the market growth.
Get more information on this report: Request Sample PDF
The global sperm density testing market is segmented by technique into colorimetric reaction, microscopy, and chromatographic immunoassay, out of which, the microscopy segment is anticipated to hold a significant share in the global sperm density testing market over the forecast period. This can be accounted to its higher accuracy and effectiveness. People prefer microscopy over other methods because it provides accurate results at reasonable pricing.
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Regionally, the global sperm density testing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the Europe region is estimated to witness noteworthy growth over the forecast period on the back of rising advancements in technology, to provide a required facility in the male infertility treatment and diagnostics field. Additionally, a large number of significant market key players are present in the Europe region. A report published by the National Library of Medicine (NLM) showed that 7.5% of European men have infertility due to lower sperm density.
Furthermore, the global sperm density testing market is also projected to grow in North America region over the forecast period owing to the higher prevalence of male infertility. Other factors, such as, late childbearing owing to delayed marriage, advanced education, and growing cases of obesity are accounted for low sperm density. A report published by the Centers for Disease Control and Prevention (CDC) in 2019 showed that there were 489 fertility clinics that perform ART in the United States. These are the major factors to provide significant opportunities to grow at a larger scale for the global sperm density testing market over the forecast period.
Get more information on this report: Request Sample PDF
The global sperm density testing market is further classified on the basis of region as follows:
North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of the Middle East and Africa) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
Our in-depth analysis of the global sperm density testing market includes the following segments:
FREQUENTLY ASKED QUESTIONS
Rising cases of male infertility worldwide, and affordability of infertility care are the major factors driving the growth of the sperm density testing market.
The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2022 - 2031.
The major players in the market are Pride Angel Ltd, DNA Forensics Laboratory Pvt. Ltd., ExSeed Health Limited, Sandstone Diagnostics, Inc., Medical Electronic System, LLC., FKA Distributing Co., LLC., AB ANALITICA s.r.l., and others.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.
The market is segmented by test type, technique, end-user, and region.
The microscopy segment is anticipated to hold the largest market size in value and is estimated to grow further over the forecast period and display significant growth opportunities.
The lack of well-trained people to perform the operations is estimated to hamper the market growth.
Europe region will provide more business opportunities for growth of sperm density testing market in future on the back of rising cases of male infertility in the region.
Related Reports
Disclaimer | Privacy Policy | Terms & Conditions
Copyright © 2021 Research Nester. All Rights Reserved
